CHG-2023-0210
Labeling Change for Mavacamtamex. New Dosage Strength for Mavacamtamex — critical change. Impacts 6 markets and 5 variations.
Change Number
CHG-2023-0210
Type
Labeling Change
Product
Status
Active
Owner
Dmitri Volkov
Initiated
2022-12-07
Description
New Dosage Strength for Mavacamtamex — critical change
Impacted Markets (6)
US — United StatesBR — BrazilES — SpainTW — TaiwanTR — TurkeyPT — Portugal
Impacted Modules
4.2.15.3.53.2.P.3
Linked Variations (0)
| Variation # | Type | Application | Status | Submitted | Approved |
|---|